Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Investment_Management
|
| gptkbp:affiliated_with |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:assets |
Billions of USD
|
| gptkbp:established_in |
gptkb:2015
|
| gptkbp:focuses_on |
Healthcare Investments
|
| gptkbp:has_partnerships_with |
Various Healthcare Institutions
|
| gptkbp:headquartered_in |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sinopharm Capital
|
| gptkbp:investment |
Pharmaceutical Companies
Biotechnology Firms Medical Device Companies |
| gptkbp:bfsParent |
gptkb:China_National_Pharmaceutical_Group_Corporation
|
| gptkbp:bfsLayer |
5
|